# Clinical Trial on Individual Characteristics Affecting Pain Drug Therapy in Neonates

> **NCT02426463** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** propofol
- **DRUG:** oxycodone

## Key facts

- **NCT ID:** NCT02426463
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-20
- **Primary completion:** 2017-02-28
- **Final completion:** 2019-01-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-02-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02426463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02426463, "Clinical Trial on Individual Characteristics Affecting Pain Drug Therapy in Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02426463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
